{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T12:17:46Z","timestamp":1772281066823,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ijaaonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.ijantimicag.2014.07.027","type":"journal-article","created":{"date-parts":[[2014,9,24]],"date-time":"2014-09-24T16:25:21Z","timestamp":1411575921000},"page":"514-519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Evaluation of the in vitro activity of levornidazole, its metabolites and comparators against clinical anaerobic bacteria"],"prefix":"10.1016","volume":"44","author":[{"given":"Jiali","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2966-9149","authenticated-orcid":false,"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haihui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuancheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2014.07.027_bib0005","first-page":"277","article-title":"Determination of the resistant mutant-preventing concentrations of four antimicrobial agents including levornidazole and justification of clinical dosage","volume":"6","author":"Wang","year":"2012","journal-title":"Prog Pharmaceut Sci"},{"key":"10.1016\/j.ijantimicag.2014.07.027_bib0010","first-page":"72","article-title":"Prevention and management of ornidazole-associated adverse reactions","volume":"1","author":"Zhao","year":"2011","journal-title":"Pharmaceut Clin Res"},{"key":"10.1016\/j.ijantimicag.2014.07.027_bib0015","first-page":"343","article-title":"Comparative study of l- and d-ornidazole in terms of central nervous system toxicity in mice","volume":"4","author":"Sun","year":"2008","journal-title":"J Chin Pharm Univ"},{"key":"10.1016\/j.ijantimicag.2014.07.027_bib0020","series-title":"Application of levornidazole in preparation of anti-anaerobic drugs. Application number CN 1686117 A. Jiangsu, China","author":"Zhang","year":"2005"},{"key":"10.1016\/j.ijantimicag.2014.07.027_bib0025","first-page":"1500","article-title":"In vitro antibacterial activity of ornidazole against 111 clinical strains of anaerobes","volume":"11","author":"Li","year":"2008","journal-title":"Acta Univer Med Nanjing (Nat Sci)"},{"key":"10.1016\/j.ijantimicag.2014.07.027_bib0030","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3109\/00498257909042323","article-title":"Metabolic studies of ornidazole in the rat, in the dog and in man","volume":"9","author":"Schwartz","year":"1979","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ijantimicag.2014.07.027_bib0035","series-title":"Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard. Document M11-A8","author":"Clinical and Laboratory Standards Institute","year":"2013"},{"key":"10.1016\/j.ijantimicag.2014.07.027_bib0040","series-title":"Performance standards for antimicrobial susceptibility testing. Twenty-fourth informational supplement. Document M100-S24","author":"Clinical and Laboratory Standards Institute","year":"2014"},{"key":"10.1016\/j.ijantimicag.2014.07.027_bib0045","first-page":"1161","article-title":"Separation of ornidazole enantiomers by high-performance liquid chromatography","volume":"13","author":"Yin","year":"2010","journal-title":"Chin J New Drug"},{"key":"10.1016\/j.ijantimicag.2014.07.027_bib0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/jcpt.12015","article-title":"Investigation of chiral inversion and pharmacokinetics of laevo-ornidazole by high-performance liquid chromatography","volume":"38","author":"Mu","year":"2013","journal-title":"J Clin Pharm Ther"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2014.07.027_bib0055","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1086\/647939","article-title":"Metronidazole is still the drug of choice for treatment of anaerobic infections","volume":"50","author":"L\u00f6fmark","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.07.027_bib0060","first-page":"412","article-title":"Phase I clinical trial of tolerance study for levornidazole tablets","volume":"16","author":"Xie","year":"2011","journal-title":"Chin J Clin Pharm Ther"},{"key":"10.1016\/j.ijantimicag.2014.07.027_bib0065","first-page":"714","article-title":"Efficacy of levornidazole sodium chloride injection in the treatment of oral anaerobic infections","volume":"6","author":"Chen","year":"2011","journal-title":"Jiangsu Med J"},{"key":"10.1016\/j.ijantimicag.2014.07.027_bib0070","first-page":"38","article-title":"Comparative clinical study of levornidazole, ornidazole, and tinidazole in treatment of pelvic inflammatory diseases","volume":"8","author":"Hao","year":"2012","journal-title":"Chin J Human Sex"},{"key":"10.1016\/j.ijantimicag.2014.07.027_bib0075","first-page":"96","article-title":"Clinical efficacy evaluation of levornidazole in treatment of intra-abdominal anaerobic infections","volume":"10","author":"Shen","year":"2012","journal-title":"Chin Med Eng"},{"key":"10.1016\/j.ijantimicag.2014.07.027_bib0080","first-page":"96","article-title":"Cost effectiveness analysis of ornidazole and metronidazole in treatment of gingivitis","volume":"21","author":"Zhang","year":"2009","journal-title":"Strait Pharm J"},{"key":"10.1016\/j.ijantimicag.2014.07.027_bib0085","first-page":"152","article-title":"Clinical observation on the therapeutic effect of ornidazole and metronidazole in treatment of gingivitis","volume":"23","author":"Pan","year":"2011","journal-title":"Strait Pharm J"},{"key":"10.1016\/j.ijantimicag.2014.07.027_bib0090","first-page":"271","article-title":"The inhibitory effects of ornidazole enantiomer on central nervous system in mice","volume":"3","author":"Chen","year":"2012","journal-title":"J Chin Pharm Univ"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857914002805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857914002805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T08:23:03Z","timestamp":1538209383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857914002805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0924857914002805"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.07.027","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the in vitro activity of levornidazole, its metabolites and comparators against clinical anaerobic bacteria","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.07.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}